I am a molecular biologist with a major research interest in genetic abnormalities in human cancers as biomarkers for cancer diagnosis, prognosis and treatment. I gained a PhD in Molecular Oncology and completed my early post-doctoral training at Cancer Research UK and Southampton University, where my research on oxidative DNA damage led to a better clarification of the cytotoxic mechanism of the anti-cancer drug 5-FU. During that period I also established a model which may help to understand the molecular consequences of unbalanced translocations in human cancer. I joined the Neuro-oncology Research Group led by Prof. Geoff Pilkington at Portsmouth University in 2009 and became an HEFCE-funded Senior Research Fellow in 2013, then in 2016 I took on a Senior Lecturer post in the School of Pharmacy & Biomedical Sciences.  Currently I am investigating mitochondrial abnormalities in the development and progression of human cancers, novel therapeutic agents targeting mitochondria, the Gas6/Axl pathway in cancer, and underlying mechanisms of cancer survival/drug resistance.

For more information about my research please visit my lab page.

Research Interests

Mitochondrial abnormalities in the development and progression of human cancers

Novel therapeutic agents targeting mitochondria

Gas6/Axl pathway in cancer

Underlying mechanisms of cancer survival/drug resistance

This site uses cookies. Click here to view our cookie policy message.

Accept and close